![Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system | Breast Cancer Research | Full Text Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system | Breast Cancer Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fbcr3105/MediaObjects/13058_2011_2964_Fig7_HTML.jpg)
Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system | Breast Cancer Research | Full Text
![Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner | British Journal of Cancer Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-0906-7/MediaObjects/41416_2020_906_Fig1_HTML.png)
Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner | British Journal of Cancer
![A novel ibuprofen derivative with anti-lung cancer properties: Synthesis, formulation, pharmacokinetic and efficacy studies - ScienceDirect A novel ibuprofen derivative with anti-lung cancer properties: Synthesis, formulation, pharmacokinetic and efficacy studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S037851731400742X-fx1.jpg)